Research ArticleBRAIN
Characterization of a First-Pass Gradient-Echo Spin-Echo Method to Predict Brain Tumor Grade and Angiogenesis
Kathleen M. Schmainda, Scott D. Rand, Allen M. Joseph, Rebecca Lund, B. Doug Ward, Arvind P. Pathak, John L. Ulmer, Michael A. Baddrudoja and Hendrikus G. J. Krouwer
American Journal of Neuroradiology October 2004, 25 (9) 1524-1532;
Kathleen M. Schmainda
Scott D. Rand
Allen M. Joseph
Rebecca Lund
B. Doug Ward
Arvind P. Pathak
John L. Ulmer
Michael A. Baddrudoja
Hendrikus G. J. Krouwer
References
- ↵(1996) 1996 Annual Report. Central Brain Tumor Registry for the United States.
- ↵Third National Cancer Survey. US National Cancer Institute;1989
- ↵Leon SP, Folkerth RD, Black P. Microvessel density is a prognostic indicator for patients with astroglial brain tumors. Cancer 1996;77:362–372
- ↵Assimakopoulou M, Sotiropoulou-Bonikou G, Maraziotis T, Papadakis N, Varakis I. Microvessel density in brain tumors. Anticancer Res 1997;17:4747–4754
- ↵Bello L, Carraba G, Giussani C, et al. Low-dose chemotherapy combined with antiangiogenic drug reduces human glioma growth in vivo. Cancer Res 2001;61:7501–7506
- Bergers G, Javaherian K, Lo K, Folkman J, Hanahan D. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. Science 1999;284:808–812
- ↵Bernsen HJ, Rijken PF, Peters JP, Bakker H, Kogel AJVD. Delayed vascular changes after angiogenic therapy with antivascular endothelial growth factor antibodies in human glioma xenografts in nude mice. Neurosurgery 1998;43:570–576
- ↵
- ↵Rosen BR, Belliveau JW, Vevea JM, Brady TJ. Perfusion imaging with NMR contrast agents. Magn Reson Med 1990;14:249–265
- ↵Maeda M, Itoh S, Kimura H, et al. Tumor vascularity in the brain: evaluation with dynamic susceptibility-contrast MR imaging. Radiology 1993;189:233–238
- Aronen HJ, Cohen MS, Belliveau JW, Fordham JA, Rosen BR. Ultrafast imaging of brain tumors. Top Magn Reson Imaging 1993;5:14–24
- ↵Aronen HJ, Gazit IE, Louis DN, et al. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 1994;191:41–51
- Guckel F, brix G, Rempp K, Deimling M, Rother J, Georgi M. Assessment of cerebral blood volume with dynamic susceptibility contrast enhanced gradient-echo imaging. J Comput Assist Tomogr 1994;18:344–351
- ↵Bruening R, Kwong KK, Vevea MJ, et al. Echo-planar MR determination of relative cerebral blood volume in human brain tumors: T1 versus T2 weighting. AJNR Am J Neuroradiol 1996;17:831–840
- ↵Siegal T, Rubinstein R, Tzuk-Shina T, Gomori JM. Utility of relative cerebral blood volume mapping derived from perfusion magnetic resonance imaging in the routine follow up of brain tumors. J Neurosurg 1997;86:22–27
- Boxerman JL, Rosen BR, Weisskoff RM. Signal-to-noise analysis of cerebral blood volume maps from dynamic NMR imaging studies. J Magn Reson Imaging 1997;7:528–537
- ↵Donahue KM, Krouwer HGJ, Rand SD, et al. Utility of simultaneously acquired gradient-echo and spin-echo cerebral blood volume and morphology maps in brain tumor patients. Magn Reson Med 2000;43:845–853
- Zhu XP, Li KL, Kamaly-Asl ID, et al. Quantification of endothelial permeability, leakage space, and blood volume in brain tumors using combined T1 and T2* contrast-enhanced dynamic MR imaging. J Magn Reson Imaging 2000;11:575–585
- ↵Aronen HJ, Pardo FS, Kennedy DN, et al. High microvascular blood volume is associated with high glucose uptake and tumor angiogenesis in human gliomas. Clin Cancer Res 2000;6:2189–2200
- ↵Sugahara T, Jorogi Y, Tomiguchi S, et al. Posttherapeutic intraaxial brain tumor: the value of perfusion-sensitive contrast-enhanced MR imaging for differentiating tumor recurrence from nonneoplastic contrast-enhancing tissue. AJNR Am J Neuroradiol 2000;21:901–909
- ↵Sugahara T, Korogi Y, Kochi M, Ushio Y, Takahashi M. Perfusion-sensitive MR imaging of gliomas: comparison between gradient-echo and spin-echo echo-planar imaging techniques. AJNR Am J Neuroradiol 2001;22:1306–1315
- Law M, Yang S, Wang H, et al. Glioma grading: sensitivity, specificity and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared to conventional imaging. AJNR Am J Neuroradiol 2003;24:1989–1998
- Knopp EA, cha S, Johnson G, et al. Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. Radiology 1999;211:791–798
- Lam WW, Chan KW, Wong WL, Poon WS, Metreweli C. Pre-operative grading of intracranial glioma. Acta Radiol 2001;42:548–554
- Kremer S, Grand S, Remy C, et al. Cerebral blood volume mapping by MR imaging in the initial evaluation of brain tumors. J Neuroradiol 2002;29:105–113
- ↵Sugahara T, Korogi Y, Shigematsu Y, et al. Value of dynamic susceptibility contrast magnetic resonance imaging in the evaluation of intracranial tumors. Top Magn Reson Imaging 1999;10:114–124
- ↵Cha S, Knopp EA, Johnson G, et al. Dynamic contrast-enhanced T2-weighted MRI imaging of recurrent malignant gliomas treated with thalidomide and carboplatin. AJNR Am J Neuroradiol 2000;21:881–890
- ↵
- ↵Fisel CR, Ackerman JL, Buxton RB, et al. MR contrast due to microscopically heterogeneous magnetic susceptibility: numerical simulations and applications to cerebral physiology. Magn Reson Med 1991;17:336–347
- ↵Boxerman JL, Hamberg LM, Rosen BR, Weisskoff RM. MR contrast due to intravascular magnetic susceptibility perturbations. Magn Reson Med 1995;34:555–566
- ↵Majumdar S, Zoghbi S, Gore JC. The influence of pulse sequence on the relaxation effects of superparamagnetic iron oxide contrast agents. Magn Reson Med 1989;10:289–301
- ↵Dennie J, Mandeville JB, Boxerman JL, Packard SD, Rosen BR, Weisskoff RM. NMR imaging of changes in vascular morphology due to tumor angiogenesis. Magn Reson Med 1998;40:793–799
- ↵Tropres I, Grimault S, Vaeth A, et al. Vessel size imaging. Magn Reson Med 2001;45:397–408
- ↵Kleihues P, Burger PC, Scheithauer BW. Histological Typing of Tumours of the Central Nervous System. New York: Springer-Verlag,1993
- ↵Weisskoff RM, Boxerman JL, Sorensen AG, Kulke SM, Campbell TA, Rosen BR. Simultaneous blood volume and permeability mapping using a single Gd-based contrast injection. Presented at: 2nd Annual Meeting of the Society of Magnetic Resonance in Medicine;1997; San Francisco, CA
- ↵Webb A. Statistical Pattern Recognition. New York: Oxford University Press,1999
- ↵Holash J, Maisonpierre PC, Compton D, et al. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 1999;284:1994–1998
- ↵Plate KH, Mennei HD. Vascular morphology and angiogenesis in glial tumors. Exp Toxicol Pathol 1995;47:89–94
- ↵Kleihues P, Louis DN, Scheithauer BW, et al. The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 2002;61:215–225
- ↵Burger PC, Vogel FS, Green SB, Strike TA. Glioblastoma multiforme and anaplastic astrocytoma: pathologic criteria and prognostic implications. Cancer 1985;56:1106–1111
- ↵
- ↵Guo P, Xu L, Pan S, et al. Vascular endothelial growth factor isoforms display distinct activities in promoting tumor angiogenesis at different anatomic sites. Cancer Res 2001;61:8569–8577
- ↵Plate KH, Breier G, Weich HA, Mennel HD, Risau W. Vascular endothelial growth factor and glioma angiogenesis: coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms. Int J Cancer 1994;59:520–529
- ↵Yuan F, Chen Y, Dellian M, Safabakhsh N, Ferrara N, Jain RK. Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an antivascular endothelial growth factor/vascular permeability factor antibody. Proc Natl Acad Sci 1996;93:14765–14770
- Allegrini PR, Muller-Driver R, Wittig C, Konerding M, Drevs J, Wood J. Effect of PTK787, a specific VEGF receptor tyrosine kinase inhibitor, on anatomy, density and permeability of tumor vessels in murine renal cell carcinoma (RENCA). Presented at: 10th Annual Meeting of the International Society of Magnetic Resonance in Medicine;2002; Honolulu, HI
- Teicher BA, Dupuis N, Kusomoto T, et al. Antiangiogenic agents can increase tumor oxygenation and responses to radiation therapy. Radiat Oncol Invest 1995;2:269–276
- ↵Kakeji Y, Teicher BA. Preclinical studies of the combination of angiogenic inhibitors with cytotoxic agents. Invest New Drugs 1997;15:39–48
- ↵Novak K. Angiogenesis inhibitors revised and revived at AACR. Nat Med 2002;8:427
- ↵Kiselev VG. On the theoretical basis of perfusion measurements by dynamic susceptibility contrast MRI. Magn Reson Med 2001;46:1113–1122
- Pathak AP, Schmainda KM, Ward BD, Linderman JR, Rebro KJ, Greene AS. MR-derived cerebral blood volume maps: issues regarding histological validation and assessment of tumor angiogenesis. Magn Reson Med 2001;46:735–747
- Pathak AP, Ward BD, Rebro KJ, Schmainda KM. The effect of brain tumor angiogenesis on the in vivo relationship between contrast agent (MION) and the gradient-echo relaxation rate change (DR2*). Presented at: 10th Annual Meeting of the International Society of Magnetic Resonance in Medicine;2002; Honolulu, HI
- Perkio J, Aronen HJ, Kangasmaki A, et al. Evaluation of four postprocessing methods for determination of cerebral blood volume and mean transit time by dynamic susceptibility contrast imaging. Magn Reson Med 2002;47:973–981
- ↵Cha S, Knopp EA, Johnson G, Wetzel SG, Litt AW, Zagzag D. Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging. Radiology 2002;223:11–29
- ↵Pathak AP, Rand SD, Schmainda KM. The effect of brain tumor angiogenesis on the in vivo relationship between the gradient-echo relaxation rate change (ΔDR2*) and contrast agent (MION) dose. J Magn Reson Imaging 2003;18:397–403
- ↵Schmainda KM, Rand SD, Joseph AM, et al. Dynamic gradient-echo and spin-echo measurements of tumor blood volume and vascular morphology predict grade in patients with brain tumors. Presented at: International Society of Magnetic Resonance in Medicine–Workshop on In Vivo Functional and Molecular Assessment of Cancer. Santa Cruz, CA;2002
- ↵Schmainda KM, Rand SD, Joseph AM, et al. A combined gradient-echo / spin-echo DSC method: a surrogate marker for brain tumor histologic grade and angiogenesis in patients. Presented at: 11th Annual Meeting of International Society of Magnetic Resonance in Medicine.2003; Toronto, Ontario, Canada
- ↵Enochs WS, Harsh G, Hochberg F, Weissleder R. Improved delineation of human brain tumors on MR images using a long-circulating, superparamagnetic iron oxide contrast agent. J Magn Reson Imaging 1999;9:228–232
In this issue
Advertisement
Characterization of a First-Pass Gradient-Echo Spin-Echo Method to Predict Brain Tumor Grade and Angiogenesis
Kathleen M. Schmainda, Scott D. Rand, Allen M. Joseph, Rebecca Lund, B. Doug Ward, Arvind P. Pathak, John L. Ulmer, Michael A. Baddrudoja, Hendrikus G. J. Krouwer
American Journal of Neuroradiology Oct 2004, 25 (9) 1524-1532;
Characterization of a First-Pass Gradient-Echo Spin-Echo Method to Predict Brain Tumor Grade and Angiogenesis
Kathleen M. Schmainda, Scott D. Rand, Allen M. Joseph, Rebecca Lund, B. Doug Ward, Arvind P. Pathak, John L. Ulmer, Michael A. Baddrudoja, Hendrikus G. J. Krouwer
American Journal of Neuroradiology Oct 2004, 25 (9) 1524-1532;
Jump to section
Related Articles
Cited By...
- Moving Toward a Consensus DSC-MRI Protocol: Validation of a Low-Flip Angle Single-Dose Option as a Reference Standard for Brain Tumors
- Optimization of Acquisition and Analysis Methods for Clinical Dynamic Susceptibility Contrast MRI Using a Population-Based Digital Reference Object
- Multisite Concordance of DSC-MRI Analysis for Brain Tumors: Results of a National Cancer Institute Quantitative Imaging Network Collaborative Project
- Impact of Software Modeling on the Accuracy of Perfusion MRI in Glioma
- ASFNR Recommendations for Clinical Performance of MR Dynamic Susceptibility Contrast Perfusion Imaging of the Brain
- Differentiation between Oligodendroglioma Genotypes Using Dynamic Susceptibility Contrast Perfusion-Weighted Imaging and Proton MR Spectroscopy
- The Effect of Pulse Sequence Parameters and Contrast Agent Dose on Percentage Signal Recovery in DSC-MRI: Implications for Clinical Applications
- Semi-automated and automated glioma grading using dynamic susceptibility-weighted contrast-enhanced perfusion MRI relative cerebral blood volume measurements
- The Role of Preload and Leakage Correction in Gadolinium-Based Cerebral Blood Volume Estimation Determined by Comparison with MION as a Criterion Standard
- Correlations between Perfusion MR Imaging Cerebral Blood Volume, Microvessel Quantification, and Clinical Outcome Using Stereotactic Analysis in Recurrent High-Grade Glioma
- Recent advances in imaging epilepsy
- Acquisition of MR perfusion images and contrast-enhanced MR angiography in acute ischaemic stroke patients: which procedure should be done first?
- Magnetic Resonance As a Cancer Imaging Biomarker
This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.
More in this TOC Section
Similar Articles
Advertisement